NNI NANOTECHNOLOGY INNOVATION SUMMIT - December 13-15, 2010,  Washington, DC
Andrew J.  Kurtz

Andrew J. Kurtz

National Cancer Institute

Office of the Director

Dr. Kurtz is a Program Director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute. His management portfolio includes both grant and contract awards to support the pre-clinical development of novel oncology therapeutics, including small molecules, biologics, and multifunctional therapeutics based on nanotechnology. From 2005-2007, Dr. Kurtz was a NIH/AAAS Science and Technology Policy Fellow, serving on the management team of The Cancer Genome Atlas Pilot Project and also assisting in the development of several program enhancements to help advance NIH-funded SBIR projects toward commercialization. Prior to coming to NIH, Dr. Kurtz conducted basic research in DNA repair, mutagenesis and carcinogenesis. He held a previous position as Research Associate at Cedra Corporation, a Contract Research Organization that provides GLP bioanalytical services to the pharmaceutical and biotechnology industries. Dr. Kurtz received a B.S. in Chemistry from The University of Texas at Austin, and a Ph.D. in Human Biological Chemistry & Genetics from The University of Texas Medical Branch at Galveston.
Program | Showcase | Sponsors | Press | Venue |
Subscribe | Contact | Site Map
© Nano Science and Technology Institute. All Rights Reserved.